Journal
SURGERY TODAY
Volume 41, Issue 11, Pages 1531-1537Publisher
SPRINGER
DOI: 10.1007/s00595-010-4453-3
Keywords
Gastric cancer; Coronary artery bypass grafting; Gastroepiploic artery; S-1; Docetaxel; Neoadjuvant chemotherapy
Categories
Funding
- Grants-in-Aid for Scientific Research [21249072, 22659246] Funding Source: KAKEN
Ask authors/readers for more resources
Cardiothoracic surgeons commonly use the internal thoracic artery (ITA) and the right gastroepiploic artery (RGEA) when performing a coronary artery bypass graft (CABG). Although the development of CABG surgery has enabled long-term survival in patients with coronary artery disease, malignant diseases are more common in older patients. We present the case of a 75-year-old man who had previously undergone CABG with the RGEA and had later developed advanced gastric cancer. We treated this patient with two courses of combination chemotherapy using S-1 and docetaxel as induction therapy, followed by successful tumor resection. Therefore, neoadjuvant chemotherapy was effective for preserving the CABG with the RGEA in a patient with advanced gastric cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available